These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2449179)

  • 1. Resensitization of hepatocyte glucagon-stimulated adenylate cyclase can be inhibited when cyclic AMP phosphodiesterase inhibitors are used to elevate intracellular cyclic AMP concentrations to supraphysiological values.
    Murphy GJ; Houslay MD
    Biochem J; 1988 Jan; 249(2):543-7. PubMed ID: 2449179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of intact hepatocytes with the calcium ionophore A23187 perturbs both the synthesis and the degradation of the second messenger cyclic AMP. Actions on adenylate cyclase and cyclic AMP phosphodiesterase activities.
    Irvine FJ; Houslay MD
    Biochem Pharmacol; 1988 Jul; 37(14):2773-9. PubMed ID: 2456067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phorbol ester TPA inhibits cyclic AMP phosphodiesterase activity in intact hepatocytes.
    Irvine F; Pyne NJ; Houslay MD
    FEBS Lett; 1986 Nov; 208(2):455-9. PubMed ID: 2430836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism.
    Murphy GJ; Hruby VJ; Trivedi D; Wakelam MJ; Houslay MD
    Biochem J; 1987 Apr; 243(1):39-46. PubMed ID: 3038085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations.
    Houslay MD
    Cell Signal; 1990; 2(1):85-98. PubMed ID: 2176803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
    Wallace AV; Heyworth CM; Houslay MD
    Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
    Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
    Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes.
    Heyworth CM; Wallace AV; Houslay MD
    Biochem J; 1983 Jul; 214(1):99-110. PubMed ID: 6311178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin, and carbachol on pancreatic acini.
    Gardner JD; Sutliff VE; Walker MD; Jensen RT
    Am J Physiol; 1983 Nov; 245(5 Pt 1):G676-80. PubMed ID: 6195928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of rat small intestinal active aldohexose transport to elevation of mucosal cyclic AMP by forskolin and 3-isobutyl-1-methylxanthine in vitro.
    Reymann A; Braun W; Woermann C
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):384-92. PubMed ID: 2419772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors.
    Hall IP; Donaldson J; Hill SJ
    Biochem Pharmacol; 1990 Apr; 39(8):1357-63. PubMed ID: 1690998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-induced refractoriness of hepatocyte adenylate cyclase: comparison of homologous and heterologous components and evidence against a role of cAMP.
    Refsnes M; Johansen EJ; Christoffersen T
    Pharmacol Toxicol; 1989 May; 64(5):397-403. PubMed ID: 2475864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone.
    Christoffersen T; Refsnes M; Brønstad GO; Ostby E; Huse J; Haffner F; Sand TE; Hunt NH; Sonne O
    Eur J Biochem; 1984 Jan; 138(2):217-26. PubMed ID: 6321168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC; Anderson N; Peachell PT
    Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phorbol ester TPA prevents the expression of both glucagon desensitisation and the glucagon-mediated block of insulin stimulation of the peripheral plasma membrane cyclic AMP phosphodiesterase in rat hepatocytes.
    Heyworth CM; Wilson SP; Gawler DJ; Houslay MD
    FEBS Lett; 1985 Aug; 187(2):196-200. PubMed ID: 2991013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M; Fredholm BB; Lerner UH
    Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type 2 diabetes.
    Portha B; Chamras H; Broer Y; Picon L; Rosselin G
    Mol Cell Endocrinol; 1983 Sep; 32(1):13-26. PubMed ID: 6313452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet-activating protein blocks glucagon desensitization in intact hepatocytes.
    Heyworth CM; Hanski E; Houslay MD
    Biochem J; 1984 Aug; 222(1):189-94. PubMed ID: 6089757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.